Active Ingredient History

  • Now
Pandemrix is an influenza vaccine for influenza pandemics, such as the 2009 flu pandemic. The vaccine was developed by GlaxoSmithKline (GSK) and patented in September 2006.   Wikipedia

More Chemistry
  • Mechanisms of Action:
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: No
a/17/ca/2009/38 (h1n1) | adimflu-s | adimflu-v | adimflu-w (h5n1) | adjuvanted h1n1 influenza vaccine | adjuvanted h1n1 influenza virus vaccine | adjuvanted h5n1 influenza virus vaccine | adjuvanted h5n1 pandemic influenza vaccine | adjuvanted inactivated novel swine origin a/h1n1 monovalent subunit influenza virus vaccine | adjuvanted inactivated whole virion h5n1 vaccine | adjuvanted seasonal trivalent inactivated influenza vaccine | adjuvanted trivalent subunit influenza vaccine | afluria | a/h1n1 influenza vaccine | a(h1n1) influenza vaccine | a/h1n1 influenza vlp vaccine | a/h1n1 pandemic influenza vaccine | a/h1n1 vaccine | a/h5n1 inactivated, split-virion influenza vaccine | a/h5n1 vaccine | a/indonesia/05/2005 (h5n1) like strain used (pr8-ibcdc-rg2) | anti-influenza vaccine | asp7374 | a/turkey h5n1 influenza vaccine | a/turkey h5n1 vaccine | begrivac | butantan fragmented inactivated trivalent influenza vaccine | cell-derived a/h1n1 influenza ha vaccine | egg-derived h5n1 influenza vaccine | egg-derived trivalent inactivated subunit influenza vaccine | eh1n1 | eh1n1_f | eh5n1 | enzira | etiv-h5n1 | fcc h5n1 | fluad | fluad h5n1 | flucelvax | fluenz | fluenz tetra | fluenz tretra | fluogen | flushield | fluviral | fluvirin | fluzone | fluzone quadrivalent | foceteria | focetria | gc3102c | gc3110 | gcflu | gc flu | gsk1557482a | gsk1557484a | gsk 1557484a | gsk-1557484a | gsk2282512a | gsk2340273a | gsk2340274a | gsk576389a | h1n1 influenza vaccine | h1n1 influenza virus vaccine | h1n1 pandemic influenza vaccine | h1n1 vaccine | h3n2 m2sr monovalent influenza vaccine | h3n2v inactivated subvirion influenza vaccine | h5n1 (6-2) aa ca recombinant | h5n1 influenza vaccine | h5n1 vaccine | h7n9 a/anhui/13 ca influenza virus vaccine | h7n9 influenza vaccine | h7n9 live influenza vaccine | h9n2 (6-2) aa ca reassortant | h9n2 influenza vaccine | h9n2 virosomal vaccine | hai-05 influenza vaccine | inactivated adjuvanted influenza vaccine | inactivated h1n1 vaccine | inactivated influenza a/h5n1 vaccine | inactivated influenza h1n1 vaccine | inactivated influenza h5n1 vaccine | inactivated influenza split vaccine | inactivated influenza vaccine | inactivated influenza vaccine trivalent types a and b | inactivated quadrivalent influenza vaccine | inactivated seasonal flu vaccine | inactivated seasonal influenza vaccine | inactivated split influenza vaccine | inactivated, split-virion influenza vaccine | inactivated split virus seasonal influenza vaccine | inactivated subvirion h7n9 influenza vaccine | inactivated trivalent influenza vaccine | inactivated vero cell based whole virus influenza a/h5n1 | inactived influenza vaccine | influenza a/california/04/2009 | influenza a/h1n1 2009 | influenza a h1n1 split virion vaccine | influenza a h1n1 whole virus vaccine | influenza a h7n7 vaccine | influenza a/vietnam/1203/2004 | influenza h1n1 monovalent vaccine | influenza h3n2 monocalen vaccine | influenza h5n1 virus monovalent vaccine | influenza h9n2 vaccine | influenza, live attenuated | influenza split vaccine | influenza vaccine | influenza vaccine, adjuvanted | influenza vaccines | influenza vaccine, split inactivated | influenza vaccine surface antigen | influenza vaccine trivalent inactivated | influenza vaccine, trivalent (tiv) | influenza vaccine (whole virion, inactivated) containing antigen of: a/vietnam/1203/2004 (h5n1) | influenza virus (inactivated, split) of the following strains:a/california/7/2009 (h1n1)pdm09 - like strain (a/california/7/2009, nymc x-179a)a/hong kong/4801/2014 (h3n2) - like strain (a/hong kong/4801/2014, nymc x-263b)b/brisbane/60/2008 - like strain (b/brisbane/60/2008, wild type) | influenza virus surface antigens (haemagglutinin and neuraminidase), inactivated, of the following strains:a/california/7/2009 (h1n1)pdm09 - like strain(a/brisbane/10/2010, wild type)a/switzerland/9715293/2013 (h3n2) - like strain(a/south australia/55/2014, wild type)b/phuket/3073/2013like strain(b/utah/9/2014, wild type) | influenza virus surface antigens (haemagglutinin and neuraminidase) of strain: a/california/7/2009 (h1n1)-derived strain used nymc x-181 7.5 microgragms per 0.5 ml dose | influenza virus surface antigens (haemagglutinin and neuraminidase) of strain: a/turkey/turkey/1/05 (h5n1)-like strain (nibrg-23) | influenza virus surface antigens (haemagglutinin and neuraminidase) of strain a/viet nam/1194/2004 (h5n1) | influenza virus surface antigens, inactivated: a/viet nam/1194/2004 (h5n1) | influenza virus vaccine | influenza virus vaccine, h5n1 | influenza virus vaccine, monovalent a/h1n1 a/california/7/2009 nymc x-179a | influenza virus vaccine, monovalent a/h5n1 a/indonesia/05/2005 | influenza virus vaccine, monovalent a/h7n9 a/shanghai/2/2013 | influenza virus vaccine, reassorted | influenza virus (whole virion, inactivated), containing antigen of: a/vietnam/1203/2004 (h5n1) | influvac | ivacflu | laiv h2n2 | laiv h5n2 | live attenuated h7n9 a/anhui/13 ca influenza virus vaccine | mg1109 | monovalen inactivated h1n1 virus vaccine | monovalent h5n1 influenza vaccine | monovalent influenza a/h5n8 vaccine | monovalent influenza a/h7n9 virus vaccine | monovalent influenza subunit virion (h5n1) vaccine, a/indonesia/05/2005 | monovalent influenza subunit virion (inactive h5n1) vaccine | monovalent influenza subvirion vaccine, h7n7 | monovalent influenza vaccine | monovalent live attenuated pandemic influenza vaccine | monovalent subvirion a/h1n1 influenza vaccine | nactived influenza vaccine | nasovac-s | nbp607 | pandemic influenza a (h1n1) vaccine | pandemic influenza a/h1n1 vaccine | pandemic influenza a/h5n1 vaccine | pandemic influenza vaccine (h5n1) (split virion, inactivated, adjuvanted) | pandemic influenza vaccine (h5n1 strain nibrg-14) | pandemrix | qiv | quadrivalent cell-culture based influenza vaccine | quadrivalent cell-culture influenza vaccine | quadrivalent inactivated influenza vaccine | quadrivalent inactivated influenza virus vaccine | quadrivalent influenza vaccine | quadrivalent influenza virus vaccine | quadrivalent subunit influenza virus vaccine | quadrivalent virosomal influenza vaccine | reassortant influenza virus (live attenuated) of the following four strains:a/california/7/2009 (h1n1)pdm09 - like strain(a/bolivia/559/2013, medi 255962)a/hong kong/4801/2014 (h3n2) - like strain(a/new caledonia/71/2014, medi 263122)b/brisbane/60/2008 - like strain(b/brisbane/60/2008, medi 228030)b/phuket/3073/2013 - like strain(b/phuket/3073/2013, medi 254977) | reassortant influenza virus (live attenuated) of the following strain: a/vietnam/1203/2004 (h5n1) strain | reassortant influenza virus (live attenuated) of the following strains: a/california/7/2009 (h1n1)pdm09 like strain, a/victoria/361/2011 (h3n2) like strain, b/massachusetts/2/2012 like strain | reassortant vaccine virus nymc x-179a | recombinant influenza ha vaccine (h5n1) | recombinant live-attenuated influenza h2n2 virus vaccine | reverse genetic reassortant a/h9n2 influenza vaccine | rhao trivalent influenza vaccine | sanofi a(h1n1) vaccine | seasonal inactivated influenza vaccine | seasonal split influenza vaccine | seasonal trivalent inactivated influenza vaccine | s-oiv h1n1 vaccine | split inactivated a/california/7/2009 (h1n1) vaccine | split, inactivated, trivalent influenza vaccine | split influenza virus, inactivated, containing antigen* : a/california/7/2009 (h1n1)v like strain (x-179a) * produced in eggs | split influenza virus, inactivated, containing antigen*: a/california/7/2009 (h1n1)v like strain (x-179a) *propagated in eggs. | split influenza virus, inactivated, containing antigen: a/vietnam/1194/2004 (h5n1) like strain used (nibrg-14) | split influenza virus inactivated, containing antigen equivalent to a/california/07/2009 (h1n1)-derived strain used nymc x-179a | split influenza virus vaccine | split-virion, adjuvanted h1n1 vaccine | split-virion, adjuvanted h5n1 vaccine | split-virion, h1n1 vaccine | split virion, inactivated influenza vaccine | split-virion, non-adjuvanted h1n1 vaccine | subvirion a/h1n1 influenza vaccine | subvirion a/h5n1 influenza vaccine | subvirion inactivated influenza a/h9n2 | surface antigen, inactivated, adjuvanted influenza vaccine | swine a/h1n1 influenza vaccine | trivalent baculovirus-expressed influenza ha vaccine | trivalent cell-culture based influenza vaccine | trivalent inactivated flu vaccine | trivalent inactivated influenza vaccine | trivalent inactivated influenza virus vaccine | trivalent influenza split vaccine | trivalent influenza vaccine | trivalent influenza virus vaccine | trivalent seasonal influenza vaccine | trivalent split influenza vaccine | trivalent split influenza virus | trivalent subunit inactivated influenza vaccine | un-adjuvanted influenza a(h1n1) vaccine | vaccine h1n1 | vaxigrip | vero cell-derived influenza vaccine | whole-virion, adjuvanted h1n1 vaccine | whole-virion, adjuvanted h5n1 vaccine | whole virion, inactivated containing antigen: a/california/07/2009 (h1n1)v | whole virion, inactivated, containing antigen*: a/vietnam/1194/2004 (h5n1) * produced in eggs


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue